Stem Cell Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Stem Cell stocks.

Stem Cell Stocks Recent News

Date Stock Title
May 17 CYRX Insider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX)
May 16 FATE Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
May 16 CELC Celcuity Inc (CELC) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...
May 15 CELC Celcuity Inc. (CELC) Q1 2024 Earnings Call Transcript
May 15 IPSC Century Therapeutics files to sell 15.87M shares of common stock for holders
May 15 CELC Celcuity Non-GAAP EPS of -$0.59
May 15 CELC Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
May 15 BCLI BrainStorm Cell Therapeutics GAAP EPS of -$0.05 beats by $0.02
May 15 BRTX BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market
May 15 BRTX BioRestorative Therapies reports Q1 results
May 14 BRTX BioRestorative Therapies, Inc. (BRTX) Q1 2024 Earnings Call Transcript
May 14 BCLI BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 14 BRTX BioRestorative Therapies Provides First Quarter 2024 Business Update
May 14 INAB IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
May 13 FATE Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
May 13 INAB IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024
May 11 FATE Fate Therapeutics, Inc. (FATE) Q1 2024 Earnings Call Transcript
May 11 CYRX Cryoport, Inc.'s (NASDAQ:CYRX) CEO Compensation Looks Acceptable To Us And Here's Why
May 11 FATE Fate Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
Stem Cell

Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells.
In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues. In a developing embryo, stem cells can differentiate into all the specialized cells—ectoderm, endoderm and mesoderm (see induced pluripotent stem cells)—but also maintain the normal turnover of regenerative organs, such as blood, skin, or intestinal tissues.
There are three known accessible sources of autologous adult stem cells in humans:
bone marrow, adipose tissue, and blood. Stem cells can also be taken from umbilical cord blood just after birth. Of all stem cell types, autologous harvesting involves the least risk. By definition, autologous cells are obtained from one's own body, just as one may bank his or her own blood for elective surgical procedures.
Adult stem cells are frequently used in various medical therapies (e.g., bone marrow transplantation). Stem cells can now be artificially grown and transformed (differentiated) into specialized cell types with characteristics consistent with cells of various tissues such as muscles or nerves. Embryonic cell lines and autologous embryonic stem cells generated through somatic cell nuclear transfer or dedifferentiation have also been proposed as promising candidates for future therapies. Research into stem cells grew out of findings by Ernest A. McCulloch and James E. Till at the University of Toronto in the 1960s.

Browse All Tags